Adenosine Deaminase (ADA) (N-Term) Peptide
ADA
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all ADA products
- ADA (Adenosine Deaminase (ADA))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- AIAGCREAIK RIAYEFVEMK AKEGVVYVEV RYSPHLLANS KVEPIPWNQA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ADA Antibody(ARP51757_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ADA (Adenosine Deaminase (ADA))
- Background
-
ADA is an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
Alias Symbols: -
Protein Interaction Partner: ADORA1,ADORA2A,ADORA2B,DPP4,DRD1,GRB2,NR3C1,ADORA1,ADORA2A,DRD1,NR3C1
Protein Size: 363 - Molecular Weight
- 41 kDa
- Gene ID
- 100
- NCBI Accession
- NM_000022, NP_000013
- UniProt
- P00813
-
You are here:
